TABLE 3

Test Result, Recommended Interventions, and Subsequent ARIs

VFSS ResultIntervention
NoneThickeningNasal Tube Feedings
HRPerson-MonthsHRa (95% CI)Person MonthsHRa (95% CI)Person-Months
NormalRef63352.18 (1.69–2.81)*20701.56 (1.18–2.07)*1935
IntermediateRef10011.30 (0.73–2.29)10032.15 (0.75–6.18)413
OPA
 AnyRef1750.59 (0.35–1.02)22130.80 (0.45–1.43)1099
 ThinRef200.49 (0.16–1.42)16790.47 (0.12–1.87)670
 ThickRef1550.40 (0.15–1.07)5340.63 (0.28–1.42)429
 CoughRef261.31 (0.26–6.76)10442.64 (0.53–13.18)463
 SilentRef1490.49 (0.26–0.90)*11690.72 (0.35–1.48)636
  • *P < .05. CI, confidence interval; HR, hazard ratio; Ref, reference.

  • a Analyzed by using shared frailty Cox regression with subsequent ARIs as outcome, adjusting for age at time of first VFSS and comorbid conditions.